AOBiome Therapeutics, Inc. is a Cambridge, MA-based life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. Founded in 2012 by PatientsLikeMe founder Jamie Heywood and MIT-trained Chemical Engineer David Whitlock, AOBiome is advancing a pipeline of multiple, clinical-stage therapeutic candidates. The company's portfolio includes multiple clinical-stage programs: a completed Phase 2 study to treat patients with acne vulgaris or acne, a Phase 1b study to treat patients with pediatric eczema (atopic dermatitis), a Phase 2a study to treat patients with adult eczema (atopic dermatitis), a Phase 2 study for the prevention of episodic migraines, and a Phase 1b/2a clinical trial for the treatment of allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications.
Company Details
- Employees
- 16
- Founded
- -
- Address
- 125 Cambridge Park Dr,
- Phone
- (617) 401-3190
- in****@****ome.com
- Industry
- Biotechnology
- Website
- aobiome.com
- HQ
- Cambridge, Massachusetts
Aobiome Therapeutics, Inc. Questions
Aobiome Therapeutics, Inc.'s helpline number is (617) 401-3190
Aobiome Therapeutics, Inc.'s website is aobiome.com
Aobiome Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/aobiome
Aobiome Therapeutics, Inc. has
16 employees.
View email and phone details for 16
employees at Aobiome Therapeutics, Inc..
Aobiome Therapeutics, Inc.'s industry is
Biotechnology
Aobiome Therapeutics, Inc.'s top competitors are
Arcaea,
Akston,
Dermavant Sciences, An Organon Company,
Finch Therapeutics,
Biopulse Solutions Pvt. Ltd.,
Alden Scientific,
Mother Dirt,
Symbiome,
Holobiome,
Solarea Bio.
Aobiome Therapeutics, Inc.'s support email address is info@aobiome.com
Aobiome Therapeutics, Inc.'s categories are Biotechnology
Aobiome Therapeutics, Inc.'s founding year is 2013
